Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources
News and Community
About us

Qiagen Pty Ltd

Regulatory activities for this sponsor.

Loading...

Cancellation by sponsor (44) Cancellation by sponsor (44)
ARTG (23) ARTG (23)
COVID-19 test kit (4) COVID-19 test kit (4)

2025 (1) 2025 (1)
2024 (22) 2024 (22)
2023 (8) 2023 (8)
2022 (4) 2022 (4)
2021 (5) 2021 (5)
2020 (4) 2020 (4)
2019 (9) 2019 (9)
2018 (1) 2018 (1)
2017 (3) 2017 (3)
2016 (3) 2016 (3)
2015 (6) 2015 (6)
2014 (3) 2014 (3)
2013 (2) 2013 (2)

Search

Sponsor content

71 result(s) found, displaying 51 to 60

Qiagen Pty Ltd - Mycobacteria IVDs Cancelled under Section 41GL(d) of the Act

20 June 2019

Cancellation by sponsor

Requested by Qiagen Pty Ltd
Qiagen Pty Ltd - Instrument/analyser IVDs Cancelled under Section 41GL(d) of the Act

20 June 2019

Cancellation by sponsor

Requested by Qiagen Pty Ltd
Qiagen Pty Ltd - Instrument/analyser IVDs Cancelled under Section 41GL(d) of the Act

20 June 2019

Cancellation by sponsor

Requested by Qiagen Pty Ltd
Qiagen Pty Ltd - Bacterial infectious disease IVDs Cancelled under Section 41GL(d) of the Act

20 June 2019

Cancellation by sponsor

Requested by Qiagen Pty Ltd
Qiagen Pty Ltd - Streptococcus IVDs Cancelled under Section 41GL(d) of the Act

20 June 2019

Cancellation by sponsor

Requested by Qiagen Pty Ltd
Qiagen Pty Ltd - Software IVDs (282962)

28 November 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Qiagen Pty Ltd - Software IVDs.
Qiagen Pty Ltd - Specimen receptacle IVDs (281880)

28 October 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Qiagen Pty Ltd - Specimen receptacle IVDs.
Qiagen Pty Ltd - Cytomegalovirus (Human herpesvirus 5) IVDs (279468)

23 August 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Qiagen Pty Ltd - Cytomegalovirus (Human herpesvirus 5) IVDs.
Qiagen Pty Ltd - Clinical chemistry-specific protein IVDs (262922)

10 November 2015

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Qiagen Pty Ltd - Clinical chemistry-specific protein IVDs.
Qiagen Pty Ltd - Cytomegalovirus (Human herpesvirus 5) IVDs (253272)

7 August 2015

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Qiagen Pty Ltd - Cytomegalovirus (Human herpesvirus 5) IVDs.

Pages

First page
Previous page
Page 1
Page 2
Page 3
Page 4
Page 5
Current page 6
Page 7
Page 8
Next page
Last page

Is there anything wrong with this page?

Help us improve this page

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control - external site
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook - external site
(formerly Twitter) - external site
Youtube - external site
Instagram - external site
LinkedIn - external site

Help us improve

We are always looking for ways to improve our website.

Provide feedback - external site

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.

Qiagen Pty Ltd

Type

Date

Help us improve this page